News

McKesson projects $36.75-$37.55 EPS for fiscal 2026 with oncology and biopharma growth
Q4 2025 Management View CEO Brian Tyler highlighted a strong finish to fiscal 2025, with consolidated revenues reaching $359 billion, a 16% growth year-over-year, and adjusted EPS of $33.05, ...
DraftKings says lack of March Madness upsets kept it from raising its forecast, but shares rally
Sports-betting platform DraftKings Inc. reported a narrower-than-expected loss for the first quarter, but said that “customer ...